EP. 1: Pathogenesis of Inflammatory Bowel Disease
EP. 2: Identifying Progressive, Relapsing IBD
EP. 3: Inflammatory Bowel Disease Risk Stratification
EP. 4: IBD Prognostication and Management
EP. 5: Diagnosing Inflammatory Bowel Disease
EP. 6: Goals of Therapy for Inflammatory Bowel Disease
EP. 7: T2T Approach for Inflammatory Bowel Disease
EP. 8: Treating a Low-Risk Inflammatory Bowel Disease
EP. 9: Treating Moderate/High-Risk IBD
EP. 10: Surgery for an Inflammatory Bowel Disease
EP. 11: Biologic Therapies for Inflammatory Bowel Disease
EP. 12: Therapeutic Outcomes for Patients With IBD
EP. 13: Implications of UNIFI in Ulcerative Colitis
EP. 14: IBD: Clinical Trial End Points and Treatment Guidance
EP. 15: Implications of the GEMINI Trial in IBD
EP. 16: Inflammatory Bowel Disease Treatment Selection
EP. 17: Switching Between Biologics for IBD
EP. 18: Optimizing Outcomes When Switching Biologics in IBD
EP. 19: Novel Therapies in the IBD Pipeline
EP. 20: Treatment Challenges in IBD
EP. 21: Role of Specialty Pharmacy in IBD Management
EP. 22: Managing Inflammatory Bowel Diseases in the Community
